83 related articles for article (PubMed ID: 25354083)
1. Fracture Risk in Women with Breast Cancer Initiating Aromatase Inhibitor Therapy: A Registry-Based Cohort Study.
Leslie WD; Morin SN; Lix LM; Niraula S; McCloskey EV; Johansson H; Harvey NC; Kanis JA
Oncologist; 2019 Nov; 24(11):1432-1438. PubMed ID: 31292269
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer and osteoporosis - management of cancer treatment-induced bone loss in postmenopausal women with breast cancer.
Kalder M; Hadji P
Breast Care (Basel); 2014 Oct; 9(5):312-7. PubMed ID: 25759610
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer, aromatase inhibitor therapy, and sexual functioning: a pilot study of the effects of vaginal testosterone therapy.
Dahir M; Travers-Gustafson D
Sex Med; 2014 Apr; 2(1):8-15. PubMed ID: 25356296
[TBL] [Abstract][Full Text] [Related]
4. Modifiable Lifestyle Factors and Breast Cancer Outcomes: Current Controversies and Research Recommendations.
Goodwin PJ; Ambrosone CB; Hong CC
Adv Exp Med Biol; 2015; 862():177-92. PubMed ID: 26059936
[TBL] [Abstract][Full Text] [Related]
5. A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors.
Hook C; Chatterjee U; Sheng H; Zhu Q; Robinson T; Roh JM; Laurent CA; Lee C; Delmerico J; Lo JC; Ambrosone CB; Kushi LH; Kwan ML; Yao S
NPJ Breast Cancer; 2024 Jan; 10(1):9. PubMed ID: 38245540
[TBL] [Abstract][Full Text] [Related]
6. Serum 25-hydroxyvitamin D and cancer-related fatigue: associations and effects on depression, anxiety, functional capacity and health-related quality of Life in breast cancer survivors during adjuvant endocrine therapy.
Custódio IDD; Nunes FSM; Lima MTM; de Carvalho KP; Alves DS; Chiaretto JF; Canto PPL; Paiva CE; de Paiva Maia YC
BMC Cancer; 2022 Aug; 22(1):860. PubMed ID: 35933326
[TBL] [Abstract][Full Text] [Related]
7. Description of Major Osteoporotic Fractures in Women with Invasive Breast Cancer Who Received Endocrine Therapy.
Lo JC; Laurent CA; Roh JM; Lee J; Chandra M; Yao S; Kwan ML
JAMA Netw Open; 2021 Nov; 4(11):e2133861. PubMed ID: 34787662
[TBL] [Abstract][Full Text] [Related]
8. Serum bone markers and risk of osteoporosis and fragility fractures in women who received endocrine therapy for breast cancer: a prospective study.
Yao S; Laurent CA; Roh JM; Lo J; Tang L; Hahn T; Ambrosone CB; Kushi LH; Kwan ML
Breast Cancer Res Treat; 2020 Feb; 180(1):187-195. PubMed ID: 31912328
[TBL] [Abstract][Full Text] [Related]
9. Distinct trajectories of fruits and vegetables, dietary fat, and alcohol intake following a breast cancer diagnosis: the Pathways Study.
Shi Z; Rundle A; Genkinger JM; Cheung YK; Ergas IJ; Roh JM; Kushi LH; Kwan ML; Greenlee H
Breast Cancer Res Treat; 2020 Jan; 179(1):229-240. PubMed ID: 31599394
[TBL] [Abstract][Full Text] [Related]
10. Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy.
Kwan ML; Yao S; Laurent CA; Roh JM; Quesenberry CP; Kushi LH; Lo JC
Breast Cancer Res Treat; 2018 Apr; 168(2):523-530. PubMed ID: 29249058
[TBL] [Abstract][Full Text] [Related]
11. Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis.
Yao S; Zhang Y; Tang L; Roh JM; Laurent CA; Hong CC; Hahn T; Lo JC; Ambrosone CB; Kushi LH; Kwan ML
Breast Cancer Res Treat; 2017 Feb; 161(3):501-513. PubMed ID: 27915435
[TBL] [Abstract][Full Text] [Related]
12. Prevention and treatment of bone fragility in cancer patient.
Ottanelli S
Clin Cases Miner Bone Metab; 2015; 12(2):116-29. PubMed ID: 26604936
[TBL] [Abstract][Full Text] [Related]
13. Bone health history in breast cancer patients on aromatase inhibitors.
Kwan ML; Lo JC; Tang L; Laurent CA; Roh JM; Chandra M; Hahn TE; Hong CC; Sucheston-Campbell L; Hershman DL; Quesenberry CP; Ambrosone CB; Kushi LH; Yao S
PLoS One; 2014; 9(10):e111477. PubMed ID: 25354083
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of lifestyle factors and bone health in breast cancer patients who received aromatase inhibitors in an integrated healthcare setting.
Kwan ML; Lo JC; Laurent CA; Roh JM; Tang L; Ambrosone CB; Kushi LH; Quesenberry CP; Yao S
J Cancer Surviv; 2023 Feb; 17(1):139-149. PubMed ID: 33565036
[TBL] [Abstract][Full Text] [Related]
15. Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study.
Pedersini R; Monteverdi S; Mazziotti G; Amoroso V; Roca E; Maffezzoni F; Vassalli L; Rodella F; Formenti AM; Frara S; Maroldi R; Berruti A; Simoncini E; Giustina A
Bone; 2017 Apr; 97():147-152. PubMed ID: 28104509
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
